393 related articles for article (PubMed ID: 17287377)
1. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension.
Piette JD; Heisler M; Ganoczy D; McCarthy JF; Valenstein M
Psychiatr Serv; 2007 Feb; 58(2):207-12. PubMed ID: 17287377
[TBL] [Abstract][Full Text] [Related]
2. Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs.
Hansen RA; Maciejewski M; Yu-Isenberg K; Farley JF
Psychiatr Serv; 2012 Sep; 63(9):920-8. PubMed ID: 22706887
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive medication adherence in the Department of Veterans Affairs.
Siegel D; Lopez J; Meier J
Am J Med; 2007 Jan; 120(1):26-32. PubMed ID: 17208076
[TBL] [Abstract][Full Text] [Related]
4. Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.
Melzer AC; Uman J; Au DH
Ann Am Thorac Soc; 2015 Jun; 12(6):831-7. PubMed ID: 25849224
[TBL] [Abstract][Full Text] [Related]
5. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?
Kreyenbuhl J; Dixon LB; McCarthy JF; Soliman S; Ignacio RV; Valenstein M
Schizophr Bull; 2010 Mar; 36(2):428-35. PubMed ID: 18718883
[TBL] [Abstract][Full Text] [Related]
6. Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medication.
Valenstein M; McCarthy JF; Ganoczy D; Bowersox NW; Dixon LB; Miller R; Visnic S; Slade EP
Psychiatr Serv; 2013 May; 64(5):445-51, 451.e1. PubMed ID: 23412131
[TBL] [Abstract][Full Text] [Related]
7. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication adherence: is there a difference between typical and atypical agents?
Dolder CR; Lacro JP; Dunn LB; Jeste DV
Am J Psychiatry; 2002 Jan; 159(1):103-8. PubMed ID: 11772697
[TBL] [Abstract][Full Text] [Related]
9. Use of antihypertensive medications among United States veterans newly diagnosed with hypertension.
Vincze G; Barner JC; Bohman T; Linn WD; Wilson JP; Johnsrud MT; Worchel J; Shepherd MD
Curr Med Res Opin; 2008 Mar; 24(3):795-805. PubMed ID: 18252038
[TBL] [Abstract][Full Text] [Related]
10. Factors related to antipsychotic oversupply among Central Texas Veterans.
Yang M; Barner JC; Worchel J
Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
[TBL] [Abstract][Full Text] [Related]
11. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
[TBL] [Abstract][Full Text] [Related]
12. Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders.
Dolder CR; Lacro JP; Jeste DV
Psychosom Med; 2003; 65(1):156-62. PubMed ID: 12554828
[TBL] [Abstract][Full Text] [Related]
13. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.
Woltmann EM; Valenstein M; Welsh DE; Lee TA; Wolschon PA; Grabowski J; Reilly PA
Psychiatr Serv; 2007 Jun; 58(6):864-7. PubMed ID: 17535949
[TBL] [Abstract][Full Text] [Related]
14. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
Rettig SM; Wood Y; Hirsch JD
J Am Pharm Assoc (2003); 2013; 53(4):427-31. PubMed ID: 23892818
[TBL] [Abstract][Full Text] [Related]
15. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
[TBL] [Abstract][Full Text] [Related]
17. Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patients with schizophrenia.
Weissman EM; Dellenbaugh C
Psychiatr Serv; 2007 Feb; 58(2):201-6. PubMed ID: 17287376
[TBL] [Abstract][Full Text] [Related]
18. Prescriber continuity and medication adherence for complex patients.
Hansen RA; Voils CI; Farley JF; Powers BJ; Sanders LL; Sleath B; Maciejewski ML
Ann Pharmacother; 2015 Mar; 49(3):293-302. PubMed ID: 25549627
[TBL] [Abstract][Full Text] [Related]
19. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
[TBL] [Abstract][Full Text] [Related]
20. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.
Valenstein M; Blow FC; Copeland LA; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Schizophr Bull; 2004; 30(2):255-64. PubMed ID: 15279044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]